Effect of Intercostal Nerve Block With Ropivacaine Combined With Mecobalamine on Chronic Pain After Thoracic Surgery
Unknown statusNot applicableNCT04217213
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This project intends to investigate the effects of intercostal nerve block with ropivacaine combined with mecobalamin on chronic post-surgical pain (CPSP) in thoracic postoperative patients. Related clinical characteristics of postoperative chronic pain. The results of the study provide clinicians with a simple and inexpensive new method of preventing CPSP, in order to prevent the occurrence of CPSP and reduce the incidence of CPSP, thereby reducing CPSP to patients and their families, hospitals. And public resources.
Study details
- Official title
- Effect of Intercostal Nerve Block With Ropivacaine Combined With Mecobalamine on Chronic Pain After Thoracic Surgery -- a Single-center Randomized, Double-blind Controlled Trial
- Conditions
- Interventions
- Procedure: Intercostal nerve block
- Sponsor
- Xuzhou Medical University
- Start date
- 2020-01-01
- Primary completion
- 2020-06-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age ≥18 years old, conscious; 2. ASA class Ⅰ \~ Ⅲ; 3. Thoracoscopic lobectomy was proposed; 4. The han nationality; 5. Native speaker of Chinese; 6. Agree to participate in this study and sign the informed consent. Exclusion Criteria: 1. Patients allergic to meccobalamin or ropivacaine; 2. Patients with previous history of chest surgery; 3. Patients with tumor invasion of chest wall, abscess, tumor intercostal neuropathy or pathological rib fracture; 4. Patients with a history of analgesic addiction or abuse, epilepsy, one or other neurological disease; 5. Diabetic patients; 6. Patients who need other drugs for pain relief but have not completed treatment or have completed treatment.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04217213